Panacea Life Sciences Holdings Overview
Get informed when a big investor buys or sells
+ Follow-0.66
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Panacea Life Sciences Holdings's p/e ratio stands at -0.66. That is below the sector sector average of 22.73. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Panacea Life Sciences Holdings sits lower the its sector benchmark (22.73) with a P/E ratio of -0.66. That is roughly 102.9% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether -0.66 is attractive depends on Panacea Life Sciences Holdings's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Panacea Life Sciences Holdings's P/E ratio evolved across reporting periods, while the comparison chart places PLSH next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
